We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Evaluating Study That Found Increased Death Risk From Paclitaxel Arterial Devices

(January 22, 2019, 9:06 AM EST) -- SILVER SPRING, Md. — The Food and Drug Administration on Jan. 17 said it is evaluating a recent review and meta-analysis showing an increased risk of death among patients treated with...
To view the full article, register now.